Humasis Co. Ltd. (KOSDAQ:205470)
734.00
-4.00 (-0.54%)
Mar 13, 2026, 3:30 PM KST
Humasis Market Cap
Humasis has a market cap or net worth of 83.05 billion as of March 13, 2026. Its market cap has decreased by -55.76% in one year.
Market Cap
83.05B
Enterprise Value
-70.61B
Revenue
35.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
734.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 83.05B, an increase of 671.65%. That is a compound annual growth rate of 27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 83.05B | -27.61% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.70T |
| Celltrion | 44.98T |
| ALTEOGEN | 19.33T |
| Sam Chun Dang Pharm. | 17.96T |
| BIT Computer | 89.66B |
| Oncocross | 87.57B |
| Gencurix | 87.27B |
| Enzychem Lifesciences | 86.56B |